Market Summary: The market size of the U.S. In Vitro Diagnostics was USD 45 billion in 2022, expected to reach USD 64.05 billion by 2032, with a revenue Compound Annual Growth Rate (CAGR) of 4% during the forecast period. The growth is fueled by increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and rising demand for personalized medicine and...